KalVista Pharmaceuticals (KALV) EPS (Diluted) (2020 - 2025)

KalVista Pharmaceuticals (KALV) EPS (Diluted) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 KalVista Pharmaceuticals 1.36 Bn 1.36 Bn 49.41 Mn -1.12

Historic Data

Download Data
DateValue
Jul 31, 2025 -1.12
Apr 30, 2025 -1.05
Oct 31, 2024 -1.11
Jul 31, 2024 -0.87
Apr 30, 2024 0.80
Jan 31, 2024 -0.84
Oct 31, 2023 -1.13
Jul 31, 2023 -1.13
Apr 30, 2023 -1.09
Jan 31, 2023 -1.32
Oct 31, 2022 -1.51
Jul 31, 2022 -1.55
Apr 30, 2022 -2.34
Jan 31, 2022 -1.55
Oct 31, 2021 -1.36
Jul 31, 2021 -0.90
Apr 30, 2021 -1.01
Jan 31, 2021 -0.74
Oct 31, 2020 -0.75
Jul 31, 2020 -0.83